The 9p21 locus: A potential therapeutic target and prognostic marker in breast cancer
M Rivandi, MS Khorrami, H Fiuji… - Journal of cellular …, 2018 - Wiley Online Library
Breast cancer is an important cause of cancer related mortality in women. Despite extensive
efforts to identify valid biomarkers for risk stratification, there are relatively few with proven …
efforts to identify valid biomarkers for risk stratification, there are relatively few with proven …
Loss of both USP10 and p14ARF protein expression is an independent prognostic biomarker for poor prognosis in patients with epithelial ovarian cancer
GH Han, DB Chay, JM Yi, H Cho… - Cancer genomics & …, 2019 - cgp.iiarjournals.org
Background/Aim: The prognostic role of USP10 in epithelial ovarian cancer has been
studied in various human cancers. Our aim was to evaluate the clinical and pathological …
studied in various human cancers. Our aim was to evaluate the clinical and pathological …
Identification of breast cancer subtype-specific biomarkers by integrating copy number alterations and gene expression profiles
Background and Objectives: Breast cancer is a heterogeneous disease categorized into four
subtypes. Previous studies have shown that copy number alterations of several genes are …
subtypes. Previous studies have shown that copy number alterations of several genes are …
Dual loss of USP10 and p14ARF protein expression is associated with poor prognosis in patients with small intestinal adenocarcinoma
JS Song, JM Yi, H Cho, CH Choi, Y Park… - Tumor …, 2018 - journals.sagepub.com
Oncogene-induced senescence occurs following oncogene activation in normal cells and is
considered as a critical tumor-suppressing mechanism. Ubiquitin-specific protease 10 …
considered as a critical tumor-suppressing mechanism. Ubiquitin-specific protease 10 …
mRNA expression of CDK2AP1 in human breast cancer: correlation with clinical and pathological parameters
R Gera, L Mokbel, WG Jiang… - Cancer genomics & …, 2018 - cgp.iiarjournals.org
Background: Cyclin-dependent kinase 2-associated protein 1 (CDK2AP1) interacts with
CDK2AP2, modulates the actions of transforming growth factor-B1, cyclin-dependent kinase …
CDK2AP2, modulates the actions of transforming growth factor-B1, cyclin-dependent kinase …
PRL-3 promotes breast cancer progression by downregulating p14ARF-mediated p53 expression
H Xie, H Wang - Oncology Letters, 2018 - spandidos-publications.com
Prior studies have demonstrated that phosphatase of regenerating liver-3 (PRL-3) serves
avital function in cell proliferation and metastasis in breast cancer. However, the molecular …
avital function in cell proliferation and metastasis in breast cancer. However, the molecular …
Transcriptional Control Leading to Clinical Outcomes in Breast Cancer Cases
Transcription is an important event that use information from a gene and make its protein.
Specific transcription factors are involved in the process that plays a role in generating gene …
Specific transcription factors are involved in the process that plays a role in generating gene …
[HTML][HTML] Study of P14/ARF Gene Promoter Methylation and Effect of Interleukin-17 Gene Polymorphism on this Methylation among Breast Cancer Patients
S Naeimi - Iranian South Medical Journal, 2016 - ismj.bpums.ac.ir
Background: hyper-methylation in CpG Island is one of the major mechanisms in gene
silencing. In many cancers, different genes are experiencing CIHM (CpG island hyper …
silencing. In many cancers, different genes are experiencing CIHM (CpG island hyper …
抑癌基因p14ARF 与p32 在喉鳞状细胞癌中的表达及其意义
张洋， 李祖飞， 许洪波， 郭伟， 黄俊伟， 黄志刚 - 中国耳鼻咽喉头颈外科, 2014 - entbjb.com
目的观察p14ARF 与p32 在喉鳞状细胞癌(laryngeal squamous cell carcinoma, LSCC)
组织中的表达情况及其与临床病理特征的关系, 探讨其对LSCC 发生发展过程中的影响 …
组织中的表达情况及其与临床病理特征的关系, 探讨其对LSCC 发生发展过程中的影响 …
Biomarcadores circulantes em mulheres com lesões impalpáveis da mama
LDR Silva - 2019 - bdtd.uerj.br
RESUMO SILVA, Lucas Delmonico Rodrigues da. Biomarcadores circulantes em mulheres
com lesões impalpáveis da mama. 2019. 178 f. Tese (Doutorado em Ciências Médicas) …
com lesões impalpáveis da mama. 2019. 178 f. Tese (Doutorado em Ciências Médicas) …